Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
Moderna Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss increased by 218.9% to $3.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.9%, from $3.13B to $3.87B. Over 4 years (FY 2021 to FY 2025), Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss shows a downward trend with a -40.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase reflects a deterioration in the market value of the fixed-income portfolio, potentially impacting shareholders' equity.
Detailed definition
The total accumulated unrealized loss amount for all debt securities in an unrealized loss position. This represents the...
Peer comparison
Standard metric for assessing the unrealized loss burden on an insurer's balance sheet.
other_debt_securities_available_for_sale_unrealized_loss_2eb75fHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.35B | $13.00B | $14.16B | $13.52B | $13.16B | $11.12B | $10.55B | $9.16B | $8.01B | $8.77B | $8.26B | $4.47B | $4.32B | $3.13B | $2.56B | $1.37B | $1.21B | $3.87B |
| QoQ Change | — | +39.1% | +8.9% | -4.5% | -2.7% | -15.5% | -5.1% | -13.2% | -12.5% | +9.4% | -5.8% | -45.9% | -3.3% | -27.6% | -18.0% | -46.6% | -11.3% | +218.9% |
| YoY Change | — | — | — | — | +40.8% | -14.5% | -25.5% | -32.2% | -39.1% | -21.1% | -21.7% | -51.3% | -46.1% | -64.4% | -69.0% | -69.4% | -71.9% | +23.9% |
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss at Other Companies
Frequently Asked Questions
- What is Moderna's debt securities, available-for-sale, unrealized loss position, accumulated loss?
- Moderna (MRNA) reported debt securities, available-for-sale, unrealized loss position, accumulated loss of $3.87B in Q1 2026.
- How has Moderna's debt securities, available-for-sale, unrealized loss position, accumulated loss changed year-over-year?
- Moderna's debt securities, available-for-sale, unrealized loss position, accumulated loss increased by 23.9% year-over-year, from $3.13B to $3.87B.
- What is the long-term trend for Moderna's debt securities, available-for-sale, unrealized loss position, accumulated loss?
- Over 4 years (2021 to 2025), Moderna's debt securities, available-for-sale, unrealized loss position, accumulated loss has grown at a -40.0% compound annual growth rate (CAGR), from $9.35B to $1.21B.
- What does debt securities, available-for-sale, unrealized loss position, accumulated loss mean?
- The total dollar amount of paper losses across all debt investments currently trading below cost.